196 related articles for article (PubMed ID: 25643439)
1. Serum paraoxonase-1 activity in children: the effects of obesity and insulin resistance.
Agirbasli M; Tanrikulu A; Erkus E; Azizy M; Sevim BA; Kaya Z; Taskin A; Aksoy N; Demirbag R
Acta Cardiol; 2014 Dec; 69(6):679-85. PubMed ID: 25643439
[TBL] [Abstract][Full Text] [Related]
2. Antioxidant status in blood of obese children: the relation between trace elements, paraoxonase, and arylesterase values.
Cayir Y; Cayir A; Turan MI; Kurt N; Kara M; Laloglu E; Ciftel M; Yildirim A
Biol Trace Elem Res; 2014 Aug; 160(2):155-60. PubMed ID: 24920129
[TBL] [Abstract][Full Text] [Related]
3. Serum paraoxonase enzyme activity and oxidative stress in obese subjects.
Aslan M; Horoz M; Sabuncu T; Celik H; Selek S
Pol Arch Med Wewn; 2011 Jun; 121(6):181-6. PubMed ID: 21694681
[TBL] [Abstract][Full Text] [Related]
4. Paraoxonase, arylesterase and lactonase activities of paraoxonase-1 (PON1) in obese and severely obese women.
Cervellati C; Bonaccorsi G; Trentini A; Valacchi G; Sanz JM; Squerzanti M; Spagnolo M; Massari L; Crivellari I; Greco P; Parladori R; Passaro A; Ricci G
Scand J Clin Lab Invest; 2018; 78(1-2):18-24. PubMed ID: 29168398
[TBL] [Abstract][Full Text] [Related]
5. Relationship of endogenous hyperleptinemia to serum paraoxonase 1, cholesteryl ester transfer protein, and lecithin cholesterol acyltransferase in obese individuals.
Bajnok L; Seres I; Varga Z; Jeges S; Peti A; Karanyi Z; Juhasz A; Csongradi E; Mezosi E; Nagy EV; Paragh G
Metabolism; 2007 Nov; 56(11):1542-9. PubMed ID: 17950106
[TBL] [Abstract][Full Text] [Related]
6. PON1 arylesterase activity, HDL functionality and their correlation in malnourished children.
Mogarekar MR; Dhabe MG; Palmate MM
J Pediatr Endocrinol Metab; 2019 Apr; 32(4):321-326. PubMed ID: 30875327
[TBL] [Abstract][Full Text] [Related]
7. Bovine paraoxonase 1 activities in serum and distribution in lipoproteins.
Miyamoto T; Takahashi Y; Oohashi T; Sato K; Oikawa S
J Vet Med Sci; 2005 Mar; 67(3):243-8. PubMed ID: 15805725
[TBL] [Abstract][Full Text] [Related]
8. Serum paraoxonase-1 activity in Helicobacter pylori infected subjects.
Aslan M; Nazligul Y; Horoz M; Bolukbas C; Bolukbas FF; Gur M; Celik H; Erel O
Atherosclerosis; 2008 Jan; 196(1):270-274. PubMed ID: 17125774
[TBL] [Abstract][Full Text] [Related]
9. Association between alcohol consumption and serum paraoxonase and arylesterase activities: a cross-sectional study within the Bavarian population.
Schwedhelm C; Nimptsch K; Bub A; Pischon T; Linseisen J
Br J Nutr; 2016 Feb; 115(4):730-6. PubMed ID: 26769660
[TBL] [Abstract][Full Text] [Related]
10. Paraoxonase (PON)-1 activity in overweight and obese children and adolescents: association with obesity-related inflammation and oxidative stress.
Krzystek-Korpacka M; Patryn E; Hotowy K; Czapińska E; Majda J; Kustrzeba-Wójcicka I; Noczyńska A; Gamian A
Adv Clin Exp Med; 2013; 22(2):229-36. PubMed ID: 23709379
[TBL] [Abstract][Full Text] [Related]
11. Altered lipid subfraction profile and impaired antioxidant defense of high-density lipoprotein in Smith-Lemli-Opitz syndrome.
Lőrincz H; Harangi M; Oláh AV; Szabó GP; Fülöp P; Somodi S; Paragh G; Seres I
Pediatr Res; 2015 May; 77(5):703-9. PubMed ID: 25668223
[TBL] [Abstract][Full Text] [Related]
12. Human paraoxonase-1 activity in childhood obesity and its relation to leptin and adiponectin levels.
Koncsos P; Seres I; Harangi M; Illyés I; Józsa L; Gönczi F; Bajnok L; Paragh G
Pediatr Res; 2010 Mar; 67(3):309-13. PubMed ID: 19915520
[TBL] [Abstract][Full Text] [Related]
13. Low protective PON1 lactonase activity in an Arab population with high rates of coronary heart disease and diabetes.
Gugliucci A; Caccavello R; Nassar H; Abu Ahmad W; Sinnreich R; Kark JD
Clin Chim Acta; 2015 May; 445():41-7. PubMed ID: 25801214
[TBL] [Abstract][Full Text] [Related]
14. Increased oxidized-LDL levels and arylesterase activity/HDL ratio in ESRD patients treated with hemodialysis.
Mahrooz A; Zargari M; Sedighi O; Shaygani H; Gohari G
Clin Invest Med; 2012 Jun; 35(3):E144-51. PubMed ID: 22673317
[TBL] [Abstract][Full Text] [Related]
15. Relationship between selected oxidative stress markers and lipid risk factors for cardiovascular disease in middle-aged adults and its possible clinical relevance.
Viktorinova A; Svitekova K; Stecova A; Krizko M
Clin Biochem; 2016 Aug; 49(12):868-72. PubMed ID: 27240017
[TBL] [Abstract][Full Text] [Related]
16. Oxidative status and serum PON1 activity in beta-thalassemia minor.
Selek S; Aslan M; Horoz M; Gur M; Erel O
Clin Biochem; 2007 Mar; 40(5-6):287-91. PubMed ID: 17296173
[TBL] [Abstract][Full Text] [Related]
17. Paraoxonase 1 activities and genetic variation in childhood obesity.
Rupérez AI; López-Guarnido O; Gil F; Olza J; Gil-Campos M; Leis R; Tojo R; Cañete R; Gil A; Aguilera CM
Br J Nutr; 2013 Nov; 110(9):1639-47. PubMed ID: 23789921
[TBL] [Abstract][Full Text] [Related]
18. The effect of lifestyle change and metformin therapy on serum arylesterase and paraoxonase activity in obese children.
Çayır A; Turan Mİ; Gurbuz F; Kurt N; Yildirim A
J Pediatr Endocrinol Metab; 2015 May; 28(5-6):551-6. PubMed ID: 25252747
[TBL] [Abstract][Full Text] [Related]
19. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy.
Abdin AA; Hassanien MA; Ibrahim EA; El-Noeman Sel-D
J Diabetes Complications; 2010; 24(5):325-33. PubMed ID: 19553142
[TBL] [Abstract][Full Text] [Related]
20. Relationship of serum resistin level to traits of metabolic syndrome and serum paraoxonase 1 activity in a population with a broad range of body mass index.
Bajnok L; Seres I; Varga Z; Jeges S; Peti A; Karanyi Z; Juhasz A; Csongradi E; Mezosi E; Nagy EV; Paragh G
Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):592-9. PubMed ID: 18465683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]